Tianjin Century Healthcare Biomedical Engineering Co., Ltd.

On January 16, 2024, the results of the 2023 Venture50 selection initiated by Qingke Entrepreneurship (1945. HK) and the investment community were finally announced! Tianjin Century Healthcare  Biomedical Engineering Co., Ltd. (hereinafter referred to as "Century Healthcare ") has been shortlisted for the first time on the "Investment Life and Health Enterprises" list!

Since 2023, Century Healthcare has continued to develop at a high speed, adding three Class III medical device registration certificates and one Class II medical device registration certificate throughout the year, including hydrophobic pre installed foldable intraocular lenses, hydrophobic non pre installed foldable intraocular lenses, collagen dressings, and intraocular lens insertion heads. As of now, Century Healthcare has accumulated 8 Class III medical device registration certificates and 3 Class II medical device registration certificates! The speed of evidence collection is unparalleled in the industry!

In the fourth batch of national procurement of high-value consumables in 2023, all artificial lens products declared by Century Healthcare have won the bid! In the same year, high-end artificial lenses, scleral lenses, and OK lenses such as Century Healthcare multifocal lenses and depth of field extensions were all clinically enrolled. The company has become an "innovative ophthalmic materials and optical technology platform enterprise" covering the fields of cataract refraction, optometry, and biomaterials collagen.

Meanwhile, Century Healthcare has also received high attention from the capital market. In 2023, well-known investment institutions such as Guotou Chuanghe, Yifeng Capital, and Haihe Fund have become strategic investors of Century Healthcare, and the company's development has also received more abundant financial support; In addition, the successful completion and acceptance of the second phase of the company's factory building has laid a solid foundation for the updating and upgrading of the enterprise's production line, as well as the sufficient supply of domestically sourced products, enhancing the company's software and hardware strength!

As evaluated by Venture50"the companies listed this year have made significant breakthroughs and achievements on the highway of technological innovation. In the future, there will be more disruptive and cutting-edge technologies to promote the growth of new industries, models, and driving forces. "Century Healthcare has a promising future!

Introduction about Venture 50

Venture50 Selection (V50), founded by Qingke Entrepreneurship (1945. HK) in 2006, has undergone 18 years of development and sublimation, and has now become a benchmark for investment value in China's high growth enterprises. As of October 2023, the total number of participating companies in the event has exceeded 75000, helping the listed companies raise more than RMB 239.456 billion, with a subsequent financing rate of 49.25% and a listing rate of approximately 15.27%.

In 2023, V50 will establish the Fengyun List, Xinya List, and Industry List based on different stages of enterprise development, gathering tens of thousands of entrepreneurial projects, inviting hundreds of investment institutions, and more than a thousand investors for evaluation. It will create a multi-dimensional interactive platform for science and technology innovation enterprises and investment institutions, bring capital assistance to many high-quality projects, and actively promote the landing of venture capital support industries, serve the real economy, and guide more venture capital and innovation forces to promote development, Create a fertile soil for technological innovation in all aspects.

nture50介绍Venture50介绍